Insider · CIK 0001297065

Lewis Michael E

Reports to the SEC for 3 companies · MISSION VIEJO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001297065

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-03-08	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Scientific Advisor	AAward	+20K sh	—	—	20,000
2016-05-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Advisor	AAward	+20K sh	—	—	20,000
2016-01-26	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$10.93	−$79.4K	314,988
2015-07-01	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$11.66	−$84.7K	322,250
2015-06-01	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$9.50	−$69K	329,512
2015-05-01	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$10.64	−$77.3K	336,774
2015-04-01	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$9.90	−$71.9K	344,036
2015-03-02	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$10.11	−$73.4K	351,298
2015-02-02	TVRDTvardi Therapeutics, Inc.S Sale	Chief Scientific Advisor	SSale	−7,262 sh	$10.60	−$77K	358,560
2014-02-05	TVRDTvardi Therapeutics, Inc. · Series D Preferred StockC Conversion	Chief Scientific Advisor	CConversion	−8,931 sh	—	—	0
2014-02-05	TVRDTvardi Therapeutics, Inc.C Conversion	Chief Scientific Advisor	CConversion	+40K sh	—	—	362,250
2014-02-05	TVRDTvardi Therapeutics, Inc.C Conversion	Chief Scientific Advisor	CConversion	+3,572 sh	—	—	365,822
2014-02-05	TVRDTvardi Therapeutics, Inc. · Series A Preferred StockC Conversion	Chief Scientific Advisor	CConversion	−100K sh	—	—	0
2014-01-30	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Scientific Advisor	AAward	+40K sh	—	—	40,000
2013-05-08	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2012-10-09	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2012-07-11	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2012-03-26	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+37K sh	—	—	37,000
2011-11-07	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2011-07-21	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2011-04-13	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2011-01-20	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+25K sh	—	—	25,000
2011-01-19	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2010-12-15	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2010-11-12	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2010-09-02	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000
2010-07-29	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2010-04-28	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2009-07-30	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2009-06-04	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2009-03-26	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2009-02-02	POLYMEDIX, INCStock Option (Right to Purchase)A Award	Director	AAward	+38.5K sh	—	—	38,500
2007-07-27	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2004-09-22	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Mar 104
Cara Therapeutics, Inc.0001209191-17-019916
SEC(opens sec.gov)
Jun 174
Cara Therapeutics, Inc.0001209191-16-128709
SEC(opens sec.gov)
Jan 274
Cara Therapeutics, Inc.0001209191-16-093830
SEC(opens sec.gov)
Jul 64
Cara Therapeutics, Inc.0001209191-15-059607
SEC(opens sec.gov)
Jun 24
Cara Therapeutics, Inc.0001209191-15-049115
SEC(opens sec.gov)
May 54
Cara Therapeutics, Inc.0001209191-15-038916
SEC(opens sec.gov)
Apr 24
Cara Therapeutics, Inc.0001209191-15-031681
SEC(opens sec.gov)
Mar 34
Cara Therapeutics, Inc.0001209191-15-021759
SEC(opens sec.gov)
Feb 34
Cara Therapeutics, Inc.0001209191-15-008991
SEC(opens sec.gov)
Feb 54
Cara Therapeutics, Inc.0001209191-14-007611
SEC(opens sec.gov)
Jan 314
Cara Therapeutics, Inc.0001209191-14-006231
SEC(opens sec.gov)
May 104
Lewis Michael E0001102624-13-000571
SEC(opens sec.gov)
Mar 64
Lewis Michael E0001102624-13-000292
SEC(opens sec.gov)
Mar 284
Lewis Michael E0001010549-12-000313
SEC(opens sec.gov)

Companies

Address

C/O AEOLUS PHARMACEUTICALS, INC. 26361 CROWN VALLEY PARKWAY #150

MISSION VIEJO, CA, 92691